INDICATORS OF HORMONAL AND CYTOKINE STATUS IN FEMALE PATIENTS OF REPRODUCTIVE AGE
https://doi.org/10.51523/2708-6011.2017-14-1-7
Abstract
About the Authors
Yu. A. LyzikovaBelarus
E. I. Rublevskaya
Belarus
E. V. Voropaev
Belarus
O. V. Osipkina
Belarus
References
1. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial / M. D. Stephenson [et al.] // Human Reproduction. - 2010. - Vol. 25, № 9. - P. 2203-2209.
2. Recurrent miscarriage: etiology, management and prognosis / T. Li [et al.] // Human Reproduction Update. - 2002. - № 8(5). - Р. 463-481.
3. Есина, Е.В. Роль иммунных взаимодействий в развитии бесплодия: обзор литературы / Е.В.Есина, Н.Ю.Логина, О.С. Аляутдина // РМЖ. - 2013. - № 1. - C.44-48.
4. Szekeres-Bartho, J. Progestagen therapy for recurrent miscarriage / J. Szekeres-Bartho, J. Balasch // Human Reproduction Update. - 2008. - Vol. 14, № 1. - P. 27-35.
5. Production of IL-4 and leukemia inhibitory factor by T cells of the cumulus oophorus a favorable microenvironment for pre-implantation embryo development / M. P. Piccini [et al.] // European Journal of Immunology. - 2001. - № 31. - P. 2431-2437.
6. Groom, K. M. Pharmacological prevention of prematurity / K. M. Groom // Best Practice & Research Clinical Obstetrics & Gynecology. - 2007. - № 21. - P. 843-856.
7. Li, T. C. Endometrial factors in recurrent miscarriage / T. C. Li, E. M. Tuckerman, S. M. Laird // Human Reproduction Update. - 2002. - № 1. - Р. 43-52.
8. Progesterone - supplementation during early gestation after IVF or ICSI has no effect on the delivery rates: a randomized controlled study / A. A. Nyboe [et al.] // Human Reproduction. - 2002. - № 2. - Р. 357-361.
Review
For citations:
Lyzikova Yu.A., Rublevskaya E.I., Voropaev E.V., Osipkina O.V. INDICATORS OF HORMONAL AND CYTOKINE STATUS IN FEMALE PATIENTS OF REPRODUCTIVE AGE. Health and Ecology Issues. 2017;(1):36-39. (In Russ.) https://doi.org/10.51523/2708-6011.2017-14-1-7